Results 281 to 290 of about 54,730 (313)

Chronic intestinal pseudo-obstruction

Current Treatment Options in Gastroenterology, 1999
For many patients, nutritional support and relief of symptoms remain the primary management goal of pseudo-obstruction. Specific pharmacological agents for this disorder are, in general, lacking. Given that the efficacy of many of the individual available agents is far from excellent, several centers have turned to combination therapy.
openaire   +2 more sources

Acute intestinal pseudo-obstruction

Current Treatment Options in Gastroenterology, 2000
Acute pseudo-obstruction may manifest clinically in one of three forms--acute gastroparesis, ileus, and acute colonic pseudo-obstruction (Ogilvie's syndrome). Though formerly associated primarily with the postoperative state, these entities are increasingly recognized in association with a wide variety of major medical problems.
openaire   +2 more sources

Intestinal Pseudo-Obstruction

Annals of Internal Medicine, 1983
Excerpt To the editor: In their article on intestinal pseudo-obstruction, Schuffler and associates (1) note that theirs was the first reported case of Ogilvie's syndrome (2) since the cases of Hand...
DAVID P. ROMEO, GLEN D. SOLOMON, ALEXANDER R. HOVER   +2 more
openaire   +1 more source

Intestinal Pseudo-Obstruction.

Annals of Internal Medicine, 1968
Excerpt In 1960 Naish and coworkers reported on a patient with recurrent episodes of intestinal obstruction associated with steatorrhea in whom no organic cause for the obstruction was found.
Jorge E. Maldonado, James A. Gregg, Paul A. Green, Martin A. Adson, Eugene Greenberg   +4 more
openaire   +1 more source

Novel ACTG2 variants disclose allelic heterogeneity and bi‐allelic inheritance in pediatric chronic intestinal pseudo‐obstruction

Clinical Genetics, 2020
Variants in the ACTG2 gene, encoding a protein crucial for correct enteric muscle contraction, have been found in patients affected with chronic intestinal pseudo‐obstruction, either congenital or late‐onset visceral myopathy, and megacystis‐microcolon ...
I. Matera, D. Bordo, M. Di Duca, M. Lerone, G. Santamaria, M. Pongiglione, A. Lezo, A. Diamanti, M. Spagnuolo, A. Pini Prato, D. Alberti, G. Mattioli, P. Gandullia, I. Ceccherini   +13 more
semanticscholar   +1 more source

Intestinal Pseudo-Obstruction Syndrome

Annual Review of Medicine, 1988
Intestinal pseudo-obstruction is a syndrome of many causes. Attempts must be made to determine the cause and the extent of the involvement of the gastrointestinal tract in each patient, because they will dictate the method of treatment for that patient. Family history must be taken from all primary chronic intestinal pseudo-obstruction patients. If it
openaire   +2 more sources

Variants in the Enteric Smooth Muscle Actin γ-2 Cause Pediatric Intestinal Pseudo-obstruction in Chinese Patients

Journal of Pediatric Gastroenterology and Nutrition - JPGN, 2020
Supplemental Digital Content is available in the text ABSTRACT Objectives: Pediatric intestinal pseudo-obstruction (PIPO) is a severe gastrointestinal disorder occurring in children, leading to failure to thrive, malnutrition, and long-term parenteral ...
Zhiliang Wei, Lina Lu, Youjie Zheng, Weihui Yan, Y. Tao, Yongtao Xiao, W. Cai, Ying Wang   +7 more
semanticscholar   +1 more source

Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction

Journal of Clinical Gastroenterology, 2018
Chronic intestinal pseudo-obstruction (CIPO) is a rare disorder characterized by an impairment of coordinated propulsive activity in the gastrointestinal (GI) tract, which clinically mimics mechanical intestinal obstruction.
Thomas J Downes, M. Cheruvu, T. Karunaratne, R. De Giorgio, A. Farmer   +4 more
semanticscholar   +1 more source

Twenty Years of Gut Transplantation for Chronic Intestinal Pseudo-obstruction: Technical Innovation, Long-term Outcome, Quality of Life, and Disease Recurrence.

Annals of Surgery, 2019
OBJECTIVE To define long-term outcome, predictors of survival, and risk of disease recurrence after gut transplantation (GT) in patients with chronic intestinal pseudo-obstruction (CIPO). BACKGROUND GT has been increasingly used to rescue patients with
H. Sogawa, G. Costa, S. Armanyous, G. Bond, R. Cruz, A. Humar, G. Mazariegos, K. Abu-Elmagd   +7 more
semanticscholar   +1 more source

Identification of a dominant MYH11 causal variant in chronic intestinal pseudo‐obstruction: Results of whole‐exome sequencing

Clinical Genetics, 2019
Chronic Intestinal Pseudo‐Obstruction (CIPO) is a rare gastrointestinal disorder, which affects the smooth muscle contractions of the gastrointestinal tract. Dominant mutations in the smooth muscle actin gene, ACTG2, accounts for 44%‐50% of CIPO patients.
W. Dong, C. Baldwin, Jungmin Choi, J. Milunsky, Junhui Zhang, K. Bilguvar, R. Lifton, A. Milunsky   +7 more
semanticscholar   +1 more source